{"id":"W2005913125","doi":"10.2165/00003495-200565110-00001","title":"Drugs in Development for Hepatitis B","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"AGE-WELL","keywords":"Lamivudine; Adefovir; Telbivudine; Entecavir; Medicine; HBeAg; Combination therapy; Hepatitis B; Pegylated interferon; Virology; Hepatitis B virus; Pharmacotherapy; Pharmacology; Immunology; Chronic hepatitis; Internal medicine; Virus; Ribavirin; HBsAg","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000362953,0.0004433397,0.002193362,0.0003435164,0.00006728953,0.00001488212,0.0001498902,0.0002668073,0.0001265162],"category_scores_gemma":[0.0001616914,0.0003741688,0.0003534857,0.0002841909,0.00004578801,0.000040932,0.0001019132,0.0003184222,0.0006819066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008284543,"about_ca_system_score_gemma":0.0008479783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003890985,"about_ca_topic_score_gemma":0.001381021,"domain_scores_codex":[0.9977936,0.00005071846,0.0008984974,0.0004702519,0.0003049756,0.0004819907],"domain_scores_gemma":[0.9990211,0.000248807,0.0002001076,0.000327661,0.00008296268,0.0001193971],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000004179708,0.00006642325,0.0003018453,0.0115148,0.0001431955,0.00001185016,0.001349869,1.847542e-8,1.506556e-8,0.00005945622,0.006458523,0.9800898],"study_design_scores_gemma":[0.0004973747,0.00003410151,0.0002224445,0.01599116,0.0003180609,0.00001069017,0.00001864796,0.000001667873,0.000001420624,0.000007448514,0.9825552,0.0003418176],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004206541,0.9887079,0.0000116956,0.0001349011,0.0002579314,0.002194249,0.00005944268,0.00006924853,0.008522579],"genre_scores_gemma":[0.00002655256,0.9877002,0.004111269,0.0002529401,0.0004623604,0.001188338,0.0003047653,0.00009885785,0.005854695],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.979748,"threshold_uncertainty_score":0.999871,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05639666729205638,"score_gpt":0.3614276505510224,"score_spread":0.305030983258966,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}